B-MoGen Biotechnologies has been awarded a grant from the NIH for -- Effective engineering of the mitochondrial genome
B-MoGen’s Leah Hogdal awarded the Minnesota Regenerative Medicine grant for - Mitochondrial Base Editing for Nerve Regeneration
B-MoGen Biotechnologies has been awarded a grant from the NIH for --
Stable Gene Transfer by RNA Delivery
B-MoGen Biotechnologies has been awarded a contract from DARPA for - Next Generation of Genome Editing Tools
Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology
B-MoGen has acquired an exclusive license to Mayo Clinic technology that allows precise introduction of deletions into the mitochondrial genome of living cells.